We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2024
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Diagnostica Stago Acquires Dutch Thrombin Generation Company

By LabMedica International staff writers
Posted on 20 Oct 2010
Diagnostica Stago, Inc. (DSI; Parsippany, NJ, USA), finalized the acquisition of Thrombinoscope, BV (Maastricht, The Netherlands). Originally developed at Maastricht University, Thrombinoscope, researches, develops, and markets thrombin generation (TG) systems through the use of the Calibrated Automated Thrombogram (CAT) system. The CAT system is available for research-only use.

"The development potential of this new TG approach in hemostasis using the CAT system is very promising," noted Stephane Zamia, Ph.D., and CEO of DSI. "The addition of this approach to Stago's portfolio will allow our customers to measure TG in real-time and in larger, scalable studies."

Operations and research at the company will remain independent within the Stago Group, and will report directly to the company's scientific and clinical department. The Stago Group believes that by remaining independently controlled, this start-up company will continue promising creativity leading to product development, citing their recent acquisition of BioCytex (Marseille, France), a company specializing in standardized kits for flow cytometric analysis of blood cells.

TG is a universal test capable of assessing a patient's global hemostatic balance in the instance of hemorrhage or thrombosis. Few methods before this had allowed for TG standardization and calibration. Thrombinoscope introduced a patented, sample-specific calibrator that allows for error correction due to inter-subject plasma composition and color variations, as well as substrate consumption. This method is both specific and sensitive, thereby giving increased relevance to this hemostatic test in academic research centers, pharmaceutical companies, and contract research organizations.

Diagnostica Stago, Inc. is the exclusive provider of the Diagnostica Stago Hemostasis product lines in the United States and offers a complete system of coagulation instruments and optimized reagent kits for research as well as for routine analysis. Diagnostica Stago, Inc. is the U.S. subsidiary of Diagnostica Stago, S.A.S. France (Asnières sur Seine, France), a developer and manufacturer of Hemostasis products.

Related Links:

Diagnostica Stago
Thrombinoscope





Gold Member
Hematology Analyzer
Swelab Lumi
Automated Blood Typing System
IH-500 NEXT
New
LH ELISA
Luteinizing Hormone ELISA
New
Silver Member
Static Concentrator
BJP 10

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries